{
    "nct_id": "NCT06120803",
    "official_title": "Effect of Esomeprazole on Radiation Induced Esophagitis in Non-small Cell Lung Cancer (EERENs): A Phase II Single Arm Study",
    "inclusion_criteria": "* Patient is â‰¥ 18 years of age.\n* Patient or patient's legal representative is willing and able to provide written informed consent and HIPAA authorization prior to performance of any study related activity.\n* Patient is willing and able to comply with scheduled visits and treatment schedules.\n* Patient has histopathologically confirmed diagnosis of NSCLC clinical stage III (as per the 8th edition of American Joint Committee on Cancer Staging).\n* Patients will receive thoracic radiation with estimated maximum dose to esophagus of at least 30 Gy (EQD2) in combination with concomitant chemotherapy.\n* Patient has Eastern Cooperative Oncology Group (ECOG) performance status score of 0 to 2.\n* Women of childbearing potential (WOCBP) must have a negative pregnancy test (serum or urine HCG) within 2 weeks of enrollment).\n* Double inclusion in any ongoing trial (if the other trial permits) will be allowed.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patient has history of gastroesophageal junction or stomach cancer.\n* Patient has history of pre-existing severe or very severe dysphagia.\n* Patient has history of severe liver disease, acute or subacute systemic lupus erythematosus.\n* Patient has interstitial nephritis.\n* Patient has history of peptic ulcer disease.\n* Patient has prior history of upper gastrointestinal bleeding.\n* Patient has a history of thoracic radiotherapy within 2 years of enrollment.\n* Patient has known or suspected allergic response and prior adverse drug reaction with proton pump inhibitors.\n* Patient is currently on clopidogrel, nelfinavir, rilpivirine, methotrexate, rifampin, digoxin, tacrolimus, or phenytoin as these may have major drug interaction with esomeprazole.\n* Patients without concomitant chemoradiotherapy and with estimated maximum dose to esophagus of less than 30 Gy (EQD2).",
    "miscellaneous_criteria": ""
}